Skip to main content
Equibles

JPMORGAN CHASE & CO

Position in SPRO — Spero Therapeutics, Inc.

CIK 19617 NEW YORK, NY
Back to SPRO Full portfolio

Position in SPRO

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$521
-$31 QoQ
Shares Held
236
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#54
of 59 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SPRO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JPMORGAN CHASE & CO holds $12,940,256,291 across 425 Biotechnology names. SPRO ranks #376 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,517,600 $3,237,487,438
2 REGN
Regeneron Pharmaceuticals, Inc.
 3,774,199 $2,353,364,036
3 INSM
INSMED Inc
 10,428,170 $1,111,851,478
4 ALNY
Alnylam Pharmaceuticals, Inc.
 2,675,517 $805,410,876
5 RVMD
Revolution Medicines, Inc.
 3,298,066 $617,661,794
6 RYTM
Rhythm Pharmaceuticals, Inc.
 2,652,746 $294,534,385
7 JAZZ
Jazz Pharmaceuticals plc
 1,160,786 $279,714,596
8 QURE
uniQure N.V.
 4,867,755 $224,208,791

All Filings in SPRO

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $521 236
2026-03-31 $552 236
2025-12-31 $12,518 5,373
2025-09-30 $443 236
2025-06-30 $684 236
2025-03-31 $43,787 60,817
2024-12-31 $63,472 61,624
2024-09-30 $316 236
2024-06-30 $306 236
2024-03-31 $405 236
2023-12-31 $346 236
2023-09-30 $285 236
2023-06-30 $342 236
2023-03-31 $342 236
2022-12-31 $408 236
2022-09-30 $3,176 1,588
2022-06-30 $944 1,275
2022-03-31 $706,195 81,172
2021-12-31 $1,555,931 97,185
2021-09-30 $1,931,833 104,934
2021-06-30 $1,617,348 115,856
2021-03-31 $1,009,335 68,569
2020-12-31 $1,428,557 73,675
2020-09-30 $1,003,149 89,888
2020-06-30 $1,349,954 99,775
2020-03-31 $631,095 78,106